The Allan Lab, Jersey General Hospital, Saint Helier, Jersey.
B-Secur Ltd, Belfast, UK.
Ann Noninvasive Electrocardiol. 2022 Sep;27(5):e12993. doi: 10.1111/anec.12993. Epub 2022 Jul 29.
Electrocardiogram (ECG) signal conditioning is a vital step in the ECG signal processing chain that ensures effective noise removal and accurate feature extraction.
This study evaluates the performance of the FDA 510 (k) cleared HeartKey Signal Conditioning and QRS peak detection algorithms on a range of annotated public and proprietary ECG databases (HeartKey is a UK Registered Trademark of B-Secur Ltd).
Seven hundred fifty-one raw ECG files from a broad range of use cases were individually passed through the HeartKey signal processing engine. The algorithms include several advanced filtering steps to enable significant noise removal and accurate identification of the QRS complex. QRS detection statistics were generated against the annotated ECG files.
HeartKey displayed robust performance across 14 ECG databases (seven public, seven proprietary), covering a range of healthy and unhealthy patient data, wet and dry electrode types, various lead configurations, hardware sources, and stationary/ambulatory recordings from clinical and non-clinical settings. Over the NSR, MIT-BIH, AHA, and MIT-AF public databases, average QRS Se and PPV values of 98.90% and 99.08% were achieved. Adaptable performance (Se 93.26%, PPV 90.53%) was similarly observed on the challenging NST database. Crucially, HeartKey's performance effectively translated to the dry electrode space, with an average QRS Se of 99.22% and PPV of 99.00% observed over eight dry electrode databases representing various use cases, including two challenging motion-based collection protocols.
HeartKey demonstrated robust signal conditioning and QRS detection performance across the broad range of tested ECG signals. It should be emphasized that in no way have the algorithms been altered or trained to optimize performance on a given database, meaning that HeartKey is potentially a universal solution capable of maintaining a high level of performance across a broad range of clinical and everyday use cases.
心电图(ECG)信号调理是 ECG 信号处理链中的重要步骤,可确保有效去除噪声并准确提取特征。
本研究评估了经 FDA 510(k)批准的 HeartKey 信号调理和 QRS 峰值检测算法在一系列标注的公共和专有 ECG 数据库上的性能(HeartKey 是 B-Secur Ltd 的英国注册商标)。
将 751 个来自广泛应用案例的原始 ECG 文件逐个通过 HeartKey 信号处理引擎。该算法包括多个高级滤波步骤,可实现显著的噪声去除和 QRS 复合体的准确识别。针对标注的 ECG 文件生成 QRS 检测统计信息。
HeartKey 在 14 个 ECG 数据库(7 个公共数据库,7 个专有数据库)中表现出稳健的性能,涵盖了健康和不健康患者数据、干湿电极类型、各种导联配置、硬件来源以及来自临床和非临床环境的固定/移动记录。在 NSR、MIT-BIH、AHA 和 MIT-AF 公共数据库中,平均 QRS Se 和 PPV 值分别达到 98.90%和 99.08%。在具有挑战性的 NST 数据库中,同样观察到适应性强的性能(Se 为 93.26%,PPV 为 90.53%)。至关重要的是,HeartKey 的性能有效地转化到干电极领域,在八个代表各种用例的干电极数据库中,平均 QRS Se 为 99.22%,PPV 为 99.00%,其中包括两个具有挑战性的基于运动的采集协议。
HeartKey 在广泛测试的 ECG 信号中表现出稳健的信号调理和 QRS 检测性能。需要强调的是,算法并未经过任何修改或训练以优化在特定数据库上的性能,这意味着 HeartKey 可能是一种通用解决方案,能够在广泛的临床和日常用例中保持高水平的性能。